Novel CAR-T Cells Target Prostate Cancer with Reduced Toxicity
In a groundbreaking advancement in cancer immunotherapy, a novel approach employing collagen-binding IL-12-armored STEAP1 CAR-T cells has shown remarkable potential in mitigating toxicity while effectively...















